Paradoxically, glucocorticoids used to suppress chronic inflammation paradoxically increase osteoporosis risk [29], while tetracycline inhibits MMP-9 activity to ameliorate bone loss [10], highlighting the complex interplay between inflammation and osteoclastogenesis. This evidence concerns the gene MMP9 and osteoporosis.